Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011849 (diabetes)
 277,896 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A 63 year old man presented with features of the glucagonoma syndrome, that is thromboembolic disease, weight loss, raised sedimentation rate, diabetes mellitus, hypoproteinaemia and reduced plasma amino acid levels, but without necrolytic migratory erythema. The plasma glucagon level was raised and the tumour was demonstrated by abdominal CT scan. Immunofluorescent studies of the resected tumour confirmed the diagnosis. The normal tissue zinc status supports the view that necrolytic migratory erythema is related to zinc deficiency.
 ...
PMID:Glucagonoma without cutaneous manifestations. 299 32

A retrospective study of eleven children affected of condyloma acuminatum is presented. Authors evaluated: age of presentation and consulting, sex, social history, predisposing factors, characteristic and extension of disease, previous venereal diseases, microscopic pathology, treatment and follow up. Age presentation ranged between 1.5 months and 14 years old. Two were male and nine were female. In two cases obvious sexual abuse was demonstrated; close contact without sexual goals in four; in two transmission during labor existed; early sexual activity in one and they didn't evidence mechanism of transmission in two. Predisposing factors include social problems, lack of hygiene, promiscuity, diabetes, ammoniacal erythema and others. Culture was positive for gonococcus in two children. VDRL test was negative in all cases. All of them were treated with 5% 5-fluorouracil cream. Recovery oscillated between seven and twenty-one days, without adverse reactions, except reddening of adjacent skin.
 ...
PMID:[Condyloma acuminatum in children]. 334 54

In healthy volunteers, possible complications at the needle site were studied during short-term as well as continuous subcutaneous infusion of aqueous fluid with portable mini-pumps. Local complications, such as leakage of fluid, erythema, and bacterial contamination of the hypodermic needle were associated with the duration of the indwelling time, but not with the total volume delivered during every experiment. The hypodermic steel needle caused pain when the subcutaneous fat tissue layer was thin. These findings may have clinical relevance for the performance of continuous subcutaneous hormone infusion therapy (e.g. insulin-pump treatment of type-I diabetes mellitus).
 ...
PMID:Cutaneous complications induced by continuous subcutaneous infusion. Experimental studies with portable mini-pumps. 340 42

Erythromelalgia is a syndrome characterized by erythema, burning pain and increased skin temperature of the affected extremities. It can be either primary (idiopathic) or secondary, but both forms require a critical temperature between 32-36 degrees C to provoke the crisis. Among the secondary forms, its association with diabetes mellitus is infrequent and its significance is little known. The histological studies have been fundamentally performed in patients with this syndrome affected by thrombocythemia; vascular thrombosis and fibromuscular intimal arteriolar proliferation were the prominent findings not corroborated in patients with the primary form. We studied one patient with acute diabetic neuropathy who developed erythromelalgia. We noted the absence of histopathological lesions, suggesting a disorder in vascular motility regulation favored by the severe neuropathy, without being able to discount a possible immunomediated mechanism. We describe the favourable evolution of the patient after treatment with aspirin and methysergide.
Diabetes Res 1988 Mar
PMID:Erythromelalgia associated with acute diabetic neuropathy: an unusual condition. 341 58

Forty unselected type I (insulin-dependent) diabetic patients with insulin pumps were examined three times for cutaneous complications and bacterial colonization of their subcutaneous catheter needles. Fifty-eight of the 120 needles were contaminated, 42 of them with Staphylococcus epidermis. Cutaneous complications, i.e, erythema of greater than or equal to 1-mm diam at the needle-insertion site, were seen with similar frequency. Significantly fewer (P less than .001) cutaneous complications and contaminated needles were found when a disinfectant was sprayed on the skin before insertion of the needle. The results indicate that infection along the indwelling subcutaneous needle contributes substantially to cutaneous complications during continuous subcutaneous insulin infusion and that these complications can successfully be prevented by appropriate antiseptic measures.
Diabetes Care
PMID:Acute cutaneous complications and catheter needle colonization during insulin-pump treatment. 362 4

A 66 year old patient with diabetes had a necrolytic migratory erythema, weight loss and anaemia. Plasma immunoreactive glucagon (IRG) of 2465 pmoles/l (normal 35 +/- 5 SEM pmoles/l) suggested the existence of a glucagonoma which was confirmed by arteriography and subsequently removed by surgery. Although plasma IRG returned to normal, glucose tolerance and insulin secretion remained pathological. Plasma amino acid levels had been reduced but were corrected by surgery. Pancreatic polypeptide, however, 298 pmoles/l before was still 206 pmoles/l after the operation (normal 12-48 pmoles per litre). Column chromatography of plasma and tumor extracts showed quantitatively important IRG fractions with molecular weights above 9000 daltons, possibly precursors of glucagon. Beside a 50-fold IRG excess, the tumour concentrations of insulin and somatostatin were 4 to 150 times increased. By contrast, pancreatic polypeptide was present in normal amounts. Electron microscopic examination showed atypical A-cell granula and unusual abundance of mitochondria.
 ...
PMID:In vitro and in vivo studies on glucagonoma tissue. 610 27

A 73-year-old man had diabetes mellitus, diarrhea, weight loss, and a rash of several years' duration. The rash, termed necrolytic migratory erythema, was the most characteristic feature and eventually suggested the diagnosis of a glucagon-secreting tumor of the pancreas. Diabetic ketoacidosis also developed in our patient, a previously unrecognized occurrence with this syndrome.
 ...
PMID:The glucagonoma syndrome. Report of a case. 624 59

Although the features of the glucagonoma syndrome had been described in isolated reports since 1942, this potentially curable condition has only recently been adequately defined. In 1974, MALLINSON collected nine cases and described the association of a peculiar skin rash with glucagon-secreting tumors of the pancreas. The typical skin rash, necrolytic migratory erythema, is accompanied by other disturbances including weight loss, anaemia, glossitis, cheilitis angularis, psychiatric symptoms. Diabetes is not a prominent feature, and the impairment of glucose tolerance can indeed be very slight. Up to 1979, about 50 cases have been reported. More than half of these patients had malignant tumors. The authors report on a 67-year-old man in whom a glucagonoma in the tail of the pancreas has been resected with apparent cure. The almost complete disappearance of the skin rash within three weeks of extirpation of the tumor has been most impressive. In June 1979 a similar tumor has been operated by one of the authors in a 60-year-old man. In this instance the tumor was located in the pancreatic corpus and could be radically resected by left-sided pancreatectomy.
 ...
PMID:[The glucagon syndrome]. 625 12

Review of the 55 reported cases of glucagon-producing tumors reveals that a distinctive clinical syndrome consisting of diabetes, a peculiar dermatitis termed necrolytic migratory erythema, weight loss and an increased tendency for thrombosis is associated with these neoplasms. Normochromic normocytic anemia, hypocholesterolemia, hypoproteinemia and generalized hypoaminoacidemia are frequent laboratory findings. Definitive diagnosis of a glucagonoma requires elevation of the fasting serum glucagon level. Selective arteriography of the pancreas has been the best method for localizing these neoplasms preoperatively, but the noninvasive technics of ultrasound and CAT scanning can also be helpful. When the tumor is benign, complete surgical excision can completely reverse all the clinical manifestations of the glucagonoma syndrome and result in lasting cure. Since, however, approximately three-fourths of these tumors are malignant, palliative therapy is frequently required. Cytoreductive surgery can decrease the amount of hormone-producing tissue and can improve or even temporarily reverse the clinical symptomatology. For disseminated disease, chemotherapy is necessary. The best results have been obtained with DTIC although streptozotocin has also been used.
 ...
PMID:Clinical aspects of glucagon-producing islet cell tumors. 627 69

Feline demodicosis, caused by Demodex cati, may be associated with immunosuppression, as from FeLV infection or diabetes mellitus. Clinical signs include nonpruritic alopecia, scaling, erythema and hyperpigmentation in the facial region. Local topical application of 2.5% lime sulfur solution every 10 days is usually curative in a few weeks or months.
 ...
PMID:Demodicosis in cats. 650 10


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>